Effect of Exenatide Use on Cognitive and Affective Functioning in Obese Patients With Type 2 Diabetes Mellitus

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Candan Yasemin Eren-Yazicioglu ◽  
Buket Kara ◽  
Seda Sancak ◽  
Sanem Pinar Uysal ◽  
Dilek Yazici ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Obese Patients ◽  
Affective Functioning

Real world data of Type 2 Diabetes Mellitus (T2DM) obese patients using another GLP1 receptor agonist (GLP1–RA) and switching to Semaglutide in Spain

2020 ◽  
Author(s):  
Jersy Cardenas ◽  
Gomez Nancy Sanchez ◽  
Sierra Poyatos Roberto Miguel ◽  
Luca Bogdana Luiza ◽  
Mostoles Naiara Modroño ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Real World ◽  
Receptor Agonist ◽  
Obese Patients ◽  
Real World Data ◽  
World Data

Glucagon-like peptide (GLP)-1 and leptin concentrations in obese patients with Type 2 diabetes mellitus

2000 ◽  
Vol 17 (10) ◽  
pp. 713-719 ◽  
Author(s):  
E. Mannucci ◽  
A. Ognibene ◽  
F. Cremasco ◽  
G. Bardini ◽  
A. Mencucci ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Obese Patients ◽  
Glucagon Like Peptide
Sign in / Sign up

Export Citation Format

Share Document